- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
How mRNA therapeutics are entering the monoclonal antibody field ; volume:17 ; number:1 ; day:22 ; month:2 ; year:2019 ; pages:1-14 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (22.2.2019), 1-14, 12.2019
- Creator
-
Hoecke, Lien Van
Roose, Kenny
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1804-8
- URN
-
urn:nbn:de:101:1-2019032023572119920373
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoecke, Lien Van
- Roose, Kenny
- SpringerLink (Online service)
Other Objects (12)
Antibody therapeutics
Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
Monoclonal antibody therapy
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics
Human antibody therapeutics for viral disease
Monoclonal antibody applications in travel medicine
In vitro-engineered non-antibody protein therapeutics
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Chemically modified mRNA Therapeutics for Bone Regeneration
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production
Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Antibody therapeutics
Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
Monoclonal antibody therapy
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics
Human antibody therapeutics for viral disease
Monoclonal antibody applications in travel medicine
In vitro-engineered non-antibody protein therapeutics
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Chemically modified mRNA Therapeutics for Bone Regeneration
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production
Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Antibody therapeutics
Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
Monoclonal antibody therapy
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics
Human antibody therapeutics for viral disease
Monoclonal antibody applications in travel medicine
In vitro-engineered non-antibody protein therapeutics
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Chemically modified mRNA Therapeutics for Bone Regeneration
Monoclonal antibody humanness score and its applications
Dynamic optimization strategies for monoclonal antibody production